SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR DURING PREGNANCY AND ALLELIC POLYMORPHISM OF RS2010963 VEGF GENE IN WOMEN WITH CONGENITAL HEART DEFECTS IN THE FETUS

  2. 2019
  3. SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR DURING PREGNANCY AND ALLELIC POLYMORPHISM OF RS2010963 VEGF GENE IN WOMEN WITH CONGENITAL HEART DEFECTS IN THE FETUS
Show/Download

Publication of the article:

«Bulletin of problems biology and medicine», 2019 Issue 3, 152,

Shargorodska E. B., Makukh G. V., Gaibonyuk I. E., Malakhova A. Y., Bobik O. B.

SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH FACTOR DURING PREGNANCY AND ALLELIC POLYMORPHISM OF rs2010963 VEGF GENE IN WOMEN WITH CONGENITAL HEART DEFECTS IN THE FETUS

About the author:

Shargorodska E. B., Makukh G. V., Gaibonyuk I. E., Malakhova A. Y., Bobik O. B.

Heading:

MEDICAL GENETICS

Type of article:

Scentific article

Annotation:

. The aim of the study was to determine the role of the maternal genotype of the rs2010963 (405С/G) loci of the VEGF gene and serum level of vascular endothelial growth factor as the risk factor of congenital heart defects in offspring. Object and Methods. The cases group consisted of 24 women who gave the fеtus with congenital heart defects. The control group included 45 women who gave birth to healthy children without a complicated genetic and obstetric history. The study used the polymerase chain reaction method, thermostable Taq polymerase oligonucleotide primers and restriction endonuclease (Thermo Fisher Scientific, USA). For the analysis of VEGF 405 C > G polymorphic loci, the RFLP method (restriction fragment length polymorphism) was used. To determine the serum concentration of vascular endothelial growth factor used a set of reagents “VEGF-ELISA-BEST”, designed to determine the concentration of VEGF in human serum by enzyme-linked immunosorbent assay. The results and discussion. According to the results of genetic testing and statistical calculations, the distribution of the genotypes and alleles of the polymorphic loci 405 C > G VEGF gene were compared with the control group. No significant association was found with the risk of CHD of the fetus according the distribution of the genotypes and alleles of the polymorphic loci 405 C > G VEGF gene (р=0.55). The serum level of vascular endothelial growth factor in pregnance women with genotype 405 GG VEGF was higher compare with another genotypes. It has been found that pregnant women with congenital heart defect in fetus have higher serum level of vascular endothelial growth factor compare with pregnant women without congenital abnormalities in fetus (p=0,029). Conclusions. The results indicate the prospect of further study of the level of endothelial growth factor in pregnant women at different stages of pregnancy, with the aim of further verification of this indicator as a marker of the congenital heart defect in fetus.

Tags:

congenital heart defects, vascular endothelial growth factor.

Bibliography:

 

  1. Kaleschke G, Baumgartner H. Pregnancy in congenital and valvular heart disease. Heart. 2011;97(21):1803-9.
  2. Rudenko NM. Likuvalna taktyka pry krytychnykh vrodzhenykh vadakh sertsia u nemovliat. Khirurhiia dytiachoho viku. 2012;3:12-8. [in Ukrainian].
  3. Shevchenko Ju, Astashev PE, Matveev SA. Endotelij – strukturnaja osnova sistemy krovoobrashhenija: istorija problemy. Vestnik Nacional’nogo mediko-hirurgicheskogo Centra im. N.I. Pirogova. 2011;6,2:9-15. [in Russian].
  4. Kaluzhyna OV. Patolohichna anatomiia lehenevoi arterii ta aorty u plodiv ta novonarodzhenykh vid materiv z uskladnenoiu vahitnistiu [dissertatsiya]. 2015. 181 s. [in Ukrainian].
  5. Ivanova OJu, Gazazjan MG, Ponomareva NA. Sostojanie vazoregulirujushhej funkcii jendotelija pri fiziologicheskom i oslozhnennom techenii beremennosti. Kurskij nauchno-prakticheskij vestnik “Chelovek i ego zdorov’e”. 2010;4:68-73. [in Russian].
  6. Jarmysh NV, Groznaja LN. Jendotelial’naja disfunkcija i ee reguljatornye faktory. Visnyk problem biolohii i medytsyny. 2014;2(111),3:37-43. [in Russian].
  7. Shapoval KI. Normalnyi ta anomalnyi rozvytok vypusknoho traktu embrionalnoho sertsia: uchast klityn nervovoho hrebnia. Morfolohiia. 2008;2,3:5-16. [in Ukrainian].
  8. Mashtalir MA, Tverdohleb IV. Gistohimicheskie, lektingistohimicheskie i immunogistohimicheskie metody v embriologicheskom issledovanii serdca. Morfologіja. 2010;4,2:39-44. [in Russian].
  9. Alekjan BG, Pursanov MG, Verin VV. Atrezija legochnoj arterii s defektom mezhzheludochkovoj peregorodki. Tihookeanskij medicinskij zhurnal. 2003;1(11):26-9. [in Russian].
  10. Zaharova NB, Durnov DA, Mihajlov VJu. Diagnosticheskoe znachenie issledovanija faktora rosta jendotelija sosudov v syvorotke krovi. Fundamental’nye issledovanija. 2011;11(1):215-20. [in Russian].
  11. Sergeevichev DS, Larionov PM, Subbotin DV. Molekuljarnyj analiz jekspressii genov semejstva VEGF v mononuklearnyh kletkah kostnogo mozga cheloveka posle plettinga. Patologija krovoobrashhenija i kardiohirurgija. 2010;1:70-5. [in Russian].
  12. Dobrzycka B, Terlikowski SJ, Kwiatkowski M. Prognostic significance of VEGF and its receptors in endometrial cancer. Ginekol Pol. 2010;81: 422-5.
  13. Ul’janina EV, Fatkullin IF. Rol’ sosudistogo jendotelial’nogo faktora rosta v prognoze sosudistyh narushenij u beremennyh s sindromom zaderzhki razvitija ploda. Kazanskij medicinskij zhurnal. 2015;96,2:220-3. [in Russian].
  14. Lim J, Thiery JP. Epithelial-mesenchymal transitions: Insights from Development. Development. 2012;139:3471-86.
  15. Lin СJ, Lin CY, Chen CH. Partitioning the heart: Mechanisms of cardiac septation and valve development. Development. 2012;139:3277-99.
  16. Crivellato E. The role of angiogenic growth factors in organogenesis. The International journal of developmental biology. 2011;55,4-5:365-75.
  17. Srivastava D. Making or breaking the heart: From lineage determination to morphogenesis. Cell. 2006;126:1037-48.
  18. Veropotveljan PN, Cehmistrenko IS, Veropotveljan NP, Glamazda AI. Sovremennyj podhod k sohraneniju reproduktivnogo potenciala. Zdorov’e zhenshhiny. 2015;9:94-7. [in Russian].
  19. Van der Linde D, Konnings E, Slager M. Birth prevalence of congenital heart disease wordwide: a systemic review and meta-analysis. J Am Cardiol. 2011;2241-7.
  20. Seema Bhargava, Tyagi SC. Nutriepigenetic regulation by folate–homocysteine–methionine axis: a review. Molecular and Cellular Biochemistry. February 2014;387:55-61.
  21. Llurba Elisa, Sánchez Olga, Ferrer, Queralt, Nicolaides. Maternal and foetal angiogenic imbalance in congenital heart defects. European heart journal. 2013;35. DOI: 10.1093/eurheartj/eht389
  22. Makukh HV, Zastavna DV, Tyrkus MYa. Pat. 32044 UA, MPK G01N33/49 (2006.01) Sposib vydilannia DNK z lejkocytiv peryferijnoi krovi, zaiavnyk DU «Instytut spadkovoi patologii NAMNU». № u200801896; zaiavl. 14.02.2008; opubl. 25.04.2008: Biul. 8. [in Ukrainian].
  23. Shkolnyk OS, Makukh HV, Marian OV. Alelnyi polimorfizm lokusu 405G/C hena VEGF (faktor rostu endoteliiu sudyn) u zhinok z patolohiieiu systemy krovoobihu. Aktualni pytannia pediatrii, akusherstva ta hinekolohii. 2014;2:132-5. Dostupno: http://nbuv.gov.ua/UJRN/appatg_2014_2_41 [in Ukrainian].
  24. Kiseleva EP, Krylov AV, Starikova JeA. Faktor rosta sosudistogo jendotelija i immunnaja sistema. Uspehi sovremennoj biologii. 2009;4:1-12. [in Russian].
  25. Scherptong RWC, Jongbloed MRM, Wisse LJ. Morphogenesis of outflow tract rotation during cardiac development: The pulmonary push concept. Developmantal dynamics. 2012;241,9:1413-22.

 

Publication of the article:

«Bulletin of problems biology and medicine» Issue 3 (152), 2019 year, 227-231 pages, index UDK 575.224.2+618.3+618.33:616.12-007-053.1+612.181

DOI:

10.29254/2077-4214-2019-3-152-227-231

2019 Issue 3, 152
05.03.2023
Was this article helpful?
28
1